XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheet - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 10,445,404 $ 4,046,937
Accounts receivable, net of allowance of $2,909 and $0, respectively 64,792 0
Other receivables 39,749 0
Unbilled accounts receivable 1,494,553 918,164
Inventory 2,276,677 1,660,710
Investments 0 1,944,464
Prepaid expenses 581,085 153,455
Total Current Assets 14,902,260 8,723,730
Long-Term Assets:    
Property and equipment, net 230,971 143,079
Intangible asset, net 988,029 1,050,022
Total Long-Term Assets 1,219,000 1,193,101
Total Assets 16,121,260 9,916,831
Current Liabilities:    
Accounts payable and accrued expenses 572,297 1,449,582
Accrued contract loss provision 500,000 0
Accrued legal settlement 135,000 0
Unearned revenue 130,000 200,109
Other liabilities 36,787 13,528
Total Current Liabilities 1,374,084 1,663,219
Total Liabilities 1,374,084 1,663,219
Stockholders' Equity    
Preferred stock: 50,000,000 Convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at December 31, 2023 and 2022, respectively 0 0
Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 132,667,107 and 126,702,545 shares issued and outstanding at December 31, 2023 and 2022, respectively 13,266 12,669
Additional paid-in capital 30,684,943 16,110,221
Accumulated deficit (15,953,504) (7,849,982)
Accumulated other comprehensive income (loss) 2,471 (19,296)
Total Stockholders' Equity 14,747,176 8,253,612
Total Liabilities and Stockholders' Equity $ 16,121,260 $ 9,916,831